Jim Tananbaum is the CEO of Foresite Capital. He was interviewed on Ideamensch earlier this month. Tananbaum explained that the idea of Foresite Capital came about after being involved in the healthcare sector for more than two decades. He realized that companies operating in that space took a longer time and more capital to succeed as compared to other sectors. Tananbaum started the firm to cater to these companies by providing the resources needed for their success. The firm analyzes information about advances in the industry to determine the most viable investment prospects. More details can be found on Ideamensch.
Jim said that most of his day revolves around taking calls, attending meetings, and discussing any updates about Foresite’s portfolio companies. Tananbaum attributes his learning nature to his productivity as an entrepreneur. He was able to grow the firm exponentially when he combined this with persistence and commitment. Jim was asked what he would change if he was able to go back. He answered that he would keep on believing in himself. Doing things as they had always been done led him to make compromises that hindered his growth. Check out Forbes to know more.
Jim Tananbaum is the founder of Foresite Capital. This is an equity firm that invests in healthcare companies. The equity firm also provides information and access to networks. Foresite Capital has recently invested in Intarcia. This is an implant that is injected into diabetes patients twice a year. It helps them to lose weight and control the disease. The product will be launched at the end of this year. Jim believes that it will change the lives of millions of people around the world.
The venture capital firm has invested in Aeri Pharmaceuticals that is developing a glaucoma treatment. The disease is one of the leading causes of blindness. The product will go a long way in reducing these cases. Other companies that the firm has invested in include Editas, Sequenta, and Nanostring. Editas is operating in the synthetic biology space. Sequenta and Nanostring are gene sequencing companies. Jim has led investments in several successful enterprises in the healthcare space including Healtheon, Amira Pharmaceuticals, Jazz Pharmaceuticals, and Amerigroup. Tananbaum has degrees from Harvard University and the Massachusetts Institute of Technology.
Check out the website officialjimtananbaum.com